Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Weir

Showing results (61-70 of 419) with videos related to

Pageof 42
Sort By:
Current Opinion in Nephrology and Hypertension|August 19, 2007
Renin inhibitors: novel agents for renoprotection or a better angiotensin receptor blocker for blood pressure lowering?Matthew R Weir
Clinical Journal of the American Society of Nephrology : CJASN|August 19, 2007
Microalbuminuria and cardiovascular diseaseMatthew R Weir
Hypertension (Dallas, Tex. : 1979)|November 2, 2011
Body mass index-mortality paradox in hemodialysis patients: blood pressure, blood volume, and nutritional statusMatthew R Weir
Hypertension (Dallas, Tex. : 1979)|December 30, 2009
Relative plasma volume monitoring and blood pressure control: an overlooked opportunity to achieve dry weight in the hemodialysis patientMatthew R Weir
Kidney International|September 24, 2017
The Author RepliesMatthew R Weir
Postgraduate Medicine|January 31, 2009
The renoprotective effects of RAS inhibition: focus on prevention and treatment of chronic kidney diseaseMatthew R Weir
The Journal of Family Practice|May 4, 2007
How big a role should JNC 7 play in the care of hypertensive patients?Matthew R Weir
Journal of Clinical Hypertension (Greenwich, Conn.)|February 1, 2008
Risk-based classification of hypertension and the role of combination therapyMatthew R Weir
The New England Journal of Medicine|July 6, 2012
Improving the estimating equation for GFR--a clinical perspectiveMatthew R Weir
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 30, 2022
The role of blood pressure control in the prevention of cardiorenal disease in patients with chronic kidney diseaseGeorge Bonifant, Matthew R Weir
Pageof 42

Showing results (61-70 of 419) with videos related to

Sort By:
Pageof 42
Current Opinion in Nephrology and Hypertension|August 19, 2007
Renin inhibitors: novel agents for renoprotection or a better angiotensin receptor blocker for blood pressure lowering?Matthew R Weir
Clinical Journal of the American Society of Nephrology : CJASN|August 19, 2007
Microalbuminuria and cardiovascular diseaseMatthew R Weir
Hypertension (Dallas, Tex. : 1979)|November 2, 2011
Body mass index-mortality paradox in hemodialysis patients: blood pressure, blood volume, and nutritional statusMatthew R Weir
Hypertension (Dallas, Tex. : 1979)|December 30, 2009
Relative plasma volume monitoring and blood pressure control: an overlooked opportunity to achieve dry weight in the hemodialysis patientMatthew R Weir
Kidney International|September 24, 2017
The Author RepliesMatthew R Weir
Postgraduate Medicine|January 31, 2009
The renoprotective effects of RAS inhibition: focus on prevention and treatment of chronic kidney diseaseMatthew R Weir
The Journal of Family Practice|May 4, 2007
How big a role should JNC 7 play in the care of hypertensive patients?Matthew R Weir
Journal of Clinical Hypertension (Greenwich, Conn.)|February 1, 2008
Risk-based classification of hypertension and the role of combination therapyMatthew R Weir
The New England Journal of Medicine|July 6, 2012
Improving the estimating equation for GFR--a clinical perspectiveMatthew R Weir
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 30, 2022
The role of blood pressure control in the prevention of cardiorenal disease in patients with chronic kidney diseaseGeorge Bonifant, Matthew R Weir
Pageof 42